Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
August 27 | 12:00 PM EDT | Zoom Personalization at scale is where every pharma content team says they’re heading. Content that adapts to the audience, performs in market, and gives you a clear read on what’s working. From emerging biotech to global pharma, that’s the shared destination. The problem is most teams try to […]
July 23 | 17:00 CET | Zoom Sometimes, it’s not the message that fails. Sometimes, it’s that nobody can trace what happened to it after it went out. Industry analysis of pharma content operations names inconsistent metadata as the single biggest barrier to omnichannel maturity, with fragmented tagging adding four to six weeks of delay […]
July 2 | 17:00 CET | 60 minutes Most pharma teams agree that Digital Opinion Leaders matter. Ask how those DOLs were selected, though, and the answers will vary. Some names come from internal recommendations. Others are discovered through LinkedIn searches, conference observations, agency suggestions, or social listening tools. Different teams apply different criteria. Follower […]
Pharma teams in EMEA operate in one of the world’s most multilingual regulatory environments. The EU alone has 24 official languages, which means global content is pretty much always translated, adapted, reviewed, and approved across many markets before it can reach HCPs or patients. The sheer scale of the markets you must cover, and the […]
Pharma and life sciences companies are constantly being pushed to create more and more content. Even though the demand for content is growing, that doesn’t mean that more content equals better. Oftentimes, it’s actually the opposite: even with limited content, you can maximize its use and value through tagging and taxonomy. The overwhelming pressure to […]
Congresses are a rare occasion of when HCPs have the time and intent to listen. HCPs come there to learn about the latest research, listen to and solve real cases, and talk to peers. Outside of the pharma congress walls, the HCP access is oftentimes much thinner. As an example, in oncology, only about 32% […]
MLR teams play one of the most critical roles in pharma — yet their contribution rarely gets the recognition it deserves. More often, MLR is seen as the bottleneck: the stage where content slows down, gets stuck in endless revision loops, or dies altogether. Content writers and marketers regularly name it as their biggest frustration. […]
You simply can’t treat medical legal regulatory (MLR) approval workflow as a guardrail when pre-review processes alone can stretch to 150 days per asset. You treat it as a bottleneck. If you want to reach HCPs in time, you need to reduce that friction. Modular content was supposed to help. But many teams try a […]
Four years sounds like a distant future. But not for the roughly 600 pharma and biotech brands that are required to complete their CRM migration by September 2030. Once they choose a platform — Salesforce Life Sciences Cloud or Veeva Vault CRM — they may have only a couple of years left to execute the […]
